13F-HR filed by Redmile Group, LLC
Redmile Group, LLC filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-16, with 86 holding rows worth $6,757,873,000.
- Accession
- 0001104659-21-106432
- Filer
- CIK 1425738
- Filed
- 2021-08-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2021
A holdings report, 86 entries on the cover page, a total value of $6,757,873,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $6,757,873,000 with VALUE read as thousands by filing date, 13F file number 028-12776. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| FATE THERAPEUTICS INC | 31189P102 | COM | 12,957,222 | $1,124,557,000 | thousands by filing date | |
| IGM BIOSCIENCES INC | 449585108 | COM | 3,425,455 | $284,998,000 | thousands by filing date | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 2,052,506 | $264,178,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 790,282 | $237,930,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 20,799,303 | $200,505,000 | thousands by filing date | |
| ALLAKOS INC | 01671P100 | COM | 2,216,996 | $189,265,000 | thousands by filing date | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 7,522,029 | $183,161,000 | thousands by filing date | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 5,619,914 | $162,921,000 | thousands by filing date | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 4,191,512 | $161,038,000 | thousands by filing date | |
| INVITAE CORP | 46185L103 | COM | 4,647,393 | $156,757,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 4,244,721 | $155,399,000 | thousands by filing date | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 860,101 | $152,788,000 | thousands by filing date | |
| MEDAVAIL HOLDINGS INC | 58406B103 | COM | 11,724,726 | $143,628,000 | thousands by filing date | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 2,072,132 | $140,905,000 | thousands by filing date | |
| OAK STR HEALTH INC | 67181A107 | COM | 2,302,653 | $134,866,000 | thousands by filing date | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 2,531,508 | $122,778,000 | thousands by filing date | |
| SEAGEN INC | 81181C104 | COM | 771,385 | $121,786,000 | thousands by filing date | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 1,936,530 | $116,676,000 | thousands by filing date | |
| SKINHEALTH SYSTEMS INC | 88331L108 | COM CL A | 6,353,246 | $106,735,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 3,012,081 | $100,724,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 6,449,577 | $100,291,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 594,732 | $98,601,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 230,558 | $98,448,000 | thousands by filing date | |
| LIVANOVA PLC | G5509L101 | SHS | 1,111,684 | $93,504,000 | thousands by filing date | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 3,156,401 | $91,914,000 | thousands by filing date | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 3,190,077 | $84,633,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 2,138,201 | $83,069,000 | thousands by filing date | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 2,458,558 | $82,755,000 | thousands by filing date | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 2,624,396 | $81,829,000 | thousands by filing date | |
| ANNEXON INC | 03589W102 | COM | 3,425,038 | $77,098,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 8,515,060 | $70,760,000 | thousands by filing date | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 2,804,944 | $69,591,000 | thousands by filing date | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 2,307,028 | $66,673,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 1,215,657 | $62,497,000 | thousands by filing date | |
| ZYMERGEN INC | 98985X100 | COM | 1,522,900 | $60,931,000 | thousands by filing date | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 8,880,945 | $58,525,000 | thousands by filing date | |
| 1LIFE HEALTHCARE INC | 68269G107 | COM | 1,666,963 | $55,110,000 | thousands by filing date | |
| NGM BIOPHARMACEUTICALS INC | 62921N105 | COM | 2,792,448 | $55,067,000 | thousands by filing date | |
| TCR2 THERAPEUTICS INC | 87808K106 | COM | 3,235,809 | $53,100,000 | thousands by filing date | |
| GENMAB A/S | 372303206 | Ordinary Shares, nominal value DKK 1 per share | 1,227,588 | $50,122,000 | thousands by filing date | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 914,035 | $49,979,000 | thousands by filing date | |
| SELECTQUOTE INC | 816307300 | COM | 2,411,957 | $46,454,000 | thousands by filing date | |
| ICU MED INC | 44930G107 | COM | 222,929 | $45,879,000 | thousands by filing date | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 4,541,009 | $42,277,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 108,801 | $41,540,000 | thousands by filing date | |
| CHARLES RIV LABS INTL INC | 159864107 | COM | 108,374 | $40,090,000 | thousands by filing date | |
| Cigna Corporation | 125523100 | COM | 159,727 | $37,866,000 | thousands by filing date | |
| UnitedHealth Group Inc | 91324P102 | COM | 94,465 | $37,828,000 | thousands by filing date | |
| NEOLEUKIN THERAPEUTICS INC | 64049K104 | COM | 3,919,235 | $36,175,000 | thousands by filing date | |
| LIFESTANCE HEALTH GROUP INC | 53228F101 | COM | 1,257,067 | $35,022,000 | thousands by filing date | |
| CATALENT INC USD 0.01 | 148806102 | COM | 310,111 | $33,529,000 | thousands by filing date | |
| ZYMEWORKS INC | 98985W102 | COM | 939,697 | $32,598,000 | thousands by filing date | |
| AMEDISYS INC | 023436108 | COM | 132,458 | $32,443,000 | thousands by filing date | |
| ALLOVIR INC | 019818103 | COM | 1,584,093 | $31,270,000 | thousands by filing date | |
| LAVA THERAPEUTICS NV | N51517105 | SHS | 2,816,196 | $30,640,000 | thousands by filing date | |
| AVITA THERAPEUTICS, INC. | 05380C102 | COM | 1,411,117 | $28,956,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 3,714,100 | $28,153,000 | thousands by filing date | |
| BIOVENTUS INC | 09075A108 | COM CL A | 1,486,956 | $26,170,000 | thousands by filing date | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 425,480 | $22,636,000 | thousands by filing date | |
| IMMATICS N.V | N44445109 | SHS | 1,941,892 | $22,545,000 | thousands by filing date | |
| PPD INC | 69355F102 | COM | 466,471 | $21,500,000 | thousands by filing date | |
| ATRECA INC | 04965G109 | COM | 2,460,268 | $20,961,000 | thousands by filing date | |
| QUANTUM SI INC | 74765K105 | COM CL A | 1,700,000 | $20,842,000 | thousands by filing date | |
| ACHILLES THERAPEUTICS PL-ADR | 00449L102 | COM | 2,088,089 | $20,442,000 | thousands by filing date | |
| GRITSTONE BIO INC | 39868T105 | COM | 2,226,206 | $20,325,000 | thousands by filing date | |
| ITAMAR MED LTD SPONSORED ADS | 465437101 | ADR | 854,900 | $20,133,000 | thousands by filing date | |
| DYNAMICS SPECIAL PURPOSE COR | 268010105 | CLASS A COM | 2,012,900 | $20,008,000 | thousands by filing date | |
| INNOVAGE HLDG CORP | 45784A104 | COM | 843,578 | $17,977,000 | thousands by filing date | |
| STEREOTAXIS INC | 85916J409 | COMMON STOCK | 1,855,504 | $17,887,000 | thousands by filing date | |
| ALPHA TEKNOVA INC | 02080L102 | COMMON STOCK | 725,000 | $17,204,000 | thousands by filing date | |
| HOOKIPA PHARMA INC | 43906K100 | COM | 1,856,205 | $17,003,000 | thousands by filing date | |
| QUANTERIX CORP | 74766Q101 | COMMON STOCK | 240,933 | $14,133,000 | thousands by filing date | |
| PROFOUND MED CORP | 74319B502 | COM NEW | 787,346 | $12,881,000 | thousands by filing date | |
| TREACE MED CONCEPTS INC | 89455T109 | COM | 323,765 | $10,121,000 | thousands by filing date | |
| CYTOSORBENTS CORP | 23283X206 | CMN | 1,304,369 | $9,848,000 | thousands by filing date | |
| AYALA PHARMACEUTICALS INC | 05465V108 | COM | 667,816 | $6,805,000 | thousands by filing date | |
| NEURONETICS INC | 64131A105 | COM | 394,355 | $6,318,000 | thousands by filing date | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 696,378 | $5,989,000 | thousands by filing date | |
| XERIS PHARMACEUTICALS INC | 98422L107 | COM | 1,358,825 | $5,530,000 | thousands by filing date | |
| ATEA PHARMACEUTICALS INC | 04683R106 | COMMON STOCK | 237,360 | $5,098,000 | thousands by filing date | |
| TALIS BIOMEDICAL CORP | 87424L108 | CMN | 363,849 | $4,013,000 | thousands by filing date | |
| APREA THERAPEUTICS INC | 03836J102 | COM | 694,918 | $3,391,000 | thousands by filing date | |
| YUMANITY THERAPEUTICS INC | 98872L102 | COM | 59,487 | $693,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 54,758 | $237,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 38,912 | $212,000 | thousands by filing date | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 40,674 | $159,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-21-106432 | this filing | 2021-08-16 | acceptance time not in the bulk data set |